- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| QSCREEN AI Aktie jetzt für 0€ handeln | |||||
| Mo | QScreen AI Inc: QScreen AI agrees to $681,000 debt settlement | 5 | Stockwatch | ||
| Mo | QScreen AI Inc.: QScreen AI Announces $681,000 Debt Settlement with Directors and Officers | 270 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen", "QAI" or the "Company"), an innovator in physiological AI screening and... ► Artikel lesen | |
| 09.09. | QScreen AI Inc: QScreen AI closes $307,662 final tranche of placement | 3 | Stockwatch | ||
| 09.09. | QScreen AI closes final tranche of private placement | 2 | Investing.com | ||
| 09.09. | QScreen AI Inc.: QScreen AI Announces Closing of Final Tranche of Non-Brokered Private Placement | 365 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 9, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, intelligence platform... ► Artikel lesen | |
| 20.07. | QScreen AI Inc: QScreen AI adds tiered workplace screening system | 3 | Stockwatch | ||
| 20.07. | QScreen AI Inc.: QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability | 350 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - QScreen AI Inc. (CSE: QAI) (OTC: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") today announced completion of the tiered screening architecture... ► Artikel lesen | |
| 14.07. | QScreen AI Inc: QScreen receives second U.S. patent | 2 | Stockwatch | ||
| 14.07. | QScreen AI Inc.: QScreen AI Secures Second US Patent, Extending Single-Camera Impairment Detection on Standard Hardware | 488 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") now holds two granted US patents covering its core impairment-detection... ► Artikel lesen | |
| 26.06. | QScreen AI Inc: QScreen AI adopts semi-annual financial reporting | 3 | Stockwatch | ||
| 26.06. | QScreen AI Inc.: QScreen AI Announces Adoption of Semi-Annual Reporting | 568 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, intelligence platform... ► Artikel lesen | |
| 25.06. | QScreen AI Inc: QScreen AI closes $243,820 first tranche of financing | 11 | Stockwatch | ||
| 25.06. | QScreen AI Inc.: QScreen AI Announces Close of First Tranche of Private Placement | 353 | Newsfile |
Toronto, Ontario--(Newsfile Corp. - June 25, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, intelligence platform... ► Artikel lesen | |
| 01.06. | QScreen AI Inc.: QScreen AI Launches European Investor Roadshow Following Recent Strategic and Technology Milestones | 432 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 1, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announced that... ► Artikel lesen | |
| 19.05. | QScreen AI Inc: QScreen AI appoints retired U.S. general as adviser | 7 | Stockwatch | ||
| 19.05. | QScreen AI Inc.: QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S. Groen (Ret.) to Advisory Board Following Live Platform Demonstration | 878 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announces the... ► Artikel lesen | |
| 06.05. | QScreen AI Inc.: QScreen AI Integrates Passive Voice Analysis into Multi-Signal Screening Platform - System Now Reads Physiological, Acoustic, and Behavioral Signals Simultaneously in Real Time | 545 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 6, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen"), today announced the full integration of a novel voice analysis engine into... ► Artikel lesen | |
| 04.05. | QScreen AI Inc: QScreen intake platform detects suicide risks | 1 | Stockwatch | ||
| 29.04. | QScreen AI Inc.: QScreen AI Appoints Former Union Pacific Vice President as Strategic Advisor to Drive Expansion into North American Rail and Transportation Markets | 485 | Newsfile | Veteran rail executive with 25 years of senior commercial relationships across North America's Class I railroads joins a platform that enables real-time identification of probable drug use from... ► Artikel lesen | |
| 27.04. | QScreen AI Inc: QScreen completes camera-based drug detection system | 3 | Stockwatch |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,810 | -0,45 % | Community-Rückblick: "Moderna wäre um min. 50% gestiegen, BioNTech bisher nicht mal 2%. That's it!" | © Foto: Julia Cebella - dpaNeue Onkologie-Daten sorgen bei BioNTech für Diskussionen: Warum reagiert die Aktie trotz guter Studienergebnisse kaum? Die wO User Diskutieren über Pipeline, Bewertung und... ► Artikel lesen | |
| APNIMED | 26,130 | -0,34 % | Apnimed, Inc.: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update | U.S. Food and Drug Administration ("FDA") Accepted the NDA for AD109, with a proposed proprietary name Oxnimbi- and assigned a PDUFA target action date of February 28,- 2027 If approved, Oxnimbi... ► Artikel lesen | |
| NOVO NORDISK | 34,340 | -1,32 % | Tagesvorschau 21. September: Novo Nordisk, UniCredit und Fed-Signal: Marktbewegende Termine zum Wochenauftakt | Novo Nordisk öffnet die Bücher, UniCredit versammelt Aktionäre - und die Fed könnte Zinshinweise liefern.Der Montag steht im Zeichen von Novo Nordisk: Der dänische Pharmariese hält seinen mit Spannung... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 17,370 | -0,06 % | Generate Biomedicines auf der H.C. Wainwright Konferenz: Plattform-Strategie im Fokus | ||
| ETON PHARMACEUTICALS | 55,23 | -0,14 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,770 | -0,21 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm (dibutepinephrine) Sublingual Film | Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026FDA will determine the resubmission classification and establish the applicable... ► Artikel lesen | |
| MERCK KGAA | 132,25 | -0,26 % | Merck strengthens commitment to China with rare disease awareness initiative | ||
| KARDIGAN | 16,320 | 0,00 % | Citi's U.S. Consumer Cards Business To Buy Kard Financial For Undisclosed Terms | WASHINGTON (dpa-AFX) - Banking major Citigroup Inc. (C) announced late Thursday that its U.S. Consumer Cards business has agreed to acquire Kard Financial, a commerce media and rewards platform.... ► Artikel lesen | |
| LB PHARMACEUTICALS | 42,990 | 0,00 % | LB Pharmaceuticals Appoints Susan Kozauer As CMO | ||
| OMNIAB | 4,580 | 0,00 % | Veraxa Biotech AG: VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb | VXA-222 advances into next phase at VERAXAZURICH, SWITZERLAND, July 27, 2026 --
VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA" or the "Company"), an emerging leader in designing novel cancer therapies... ► Artikel lesen | |
| SEAPORT THERAPEUTICS | 21,150 | +0,14 % | Seaport Therapeutics Prices Upsized IPO Of 14.16 Mln Shares At $18 Each | WASHINGTON (dpa-AFX) - Seaport Therapeutics, Inc. (SPTX) said it has priced its upsized initial public offering of 14.16 shares at $18 per share, at the top of the target range. The company... ► Artikel lesen | |
| KAZIA THERAPEUTICS | 10,650 | 0,00 % | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | ||
| JOURNEY MEDICAL | 6,995 | +0,07 % | Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights | Total revenues were $18.5 million for the second quarter of 2026, reflecting 23% growth from the prior-year quarter Emrosi revenues were $8.1 million for the second quarter of 2026 Strong revenue... ► Artikel lesen | |
| ATRIUM THERAPEUTICS | 9,180 | 0,00 % | Atrium Therapeutics Reports Second Quarter 2026 Financial Results | -- IND clearance for ATR 1072 and launch of Corventis Phase 1/2 trial in PRKAG2 syndrome --
-- Achieved second milestone payment under global cardiovascular collaboration... ► Artikel lesen | |
| DATAMEDS AI | 4,210 | +0,72 % | DataMEDS AI, Inc.: DataMEDS AI Unveils New Corporate Website | Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement TAMPA, FL / ACCESS Newswire / September 21, 2026... ► Artikel lesen |
QSCREEN AI INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,008 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QSCREEN AI INC finden Sie auf Wallstreet Online.